Edwards Lifesciences (EW) Short-Term Debt repayments (2010 - 2013)

Edwards Lifesciences' Short-Term Debt repayments history runs 4 years deep, the most recent figure standing at $67.8 million for Q3 2013.

• In Q3 2013, Short-Term Debt repayments rose 59.15% year-over-year to $67.8 million; the TTM figure through Sep 2013 stood at $515.7 million (up 100.97% YoY), while the FY2012 annual figure was $367.5 million, down 12.85% from the prior year.
• Short-Term Debt repayments was $67.8 million for Q3 2013 at Edwards Lifesciences, down from $133.7 million in the prior quarter.
• In the past five years, Short-Term Debt repayments ranged from a high of $305.4 million in Q3 2011 to a low of $5.2 million in Q1 2011.
• Historically, Short-Term Debt repayments has averaged $96.8 million across 4 years, with a median of $67.8 million in 2013.
• The sharpest annual moves came in 2011 and 2012: Short-Term Debt repayments tumbled 91.93% in 2011, then jumped 2217.31% in 2012.
• A 4-year view of Short-Term Debt repayments shows it stood at $95.2 million in 2010, then tumbled by 52.73% to $45.0 million in 2011, then jumped by 246.44% to $155.9 million in 2012, then plunged by 56.51% to $67.8 million in 2013.
• The last three Short-Term Debt repayments figures came in at $67.8 million (Q3 2013), $133.7 million (Q2 2013), and $158.3 million (Q1 2013), per Business Quant data.